<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00775892</url>
  </required_header>
  <id_info>
    <org_study_id>CLN-ACL1B</org_study_id>
    <nct_id>NCT00775892</nct_id>
  </id_info>
  <brief_title>SeriACL™ Device (Gen IB) Trial for Anterior Cruciate Ligament (ACL) Repair</brief_title>
  <official_title>A Multi-Center Open Label Study to Evaluate the SeriACL™ Device (Gen IB) for Primary Anterior Cruciate Ligament Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Serica Technologies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Serica Technologies, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi-center single-arm clinical trial is being conducted to evaluate SeriACL device safety
      and performance during total anterior cruciate ligament (ACL) reconstruction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety - Adverse Events</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>KT-1000 Arthrometer Knee Laxity</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knee Surveys</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Anterior Cruciate Ligament Reconstruction</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SeriACL Device ACL Reconstruction</intervention_name>
    <description>Long-term Bioresorbable ACL Scaffold</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Major Inclusion Criteria:

          -  Complete rupture of the ACL

          -  Passive flexion &gt;= 120° and passive extension = contralateral knee

          -  MCL grade 2 or less

          -  Pre-injury Tegner score &gt;= 4

          -  Informed Consent

        Major Exclusion Criteria:

          -  Prior ACL reconstruction.

          -  Severe pain, swelling, or redness

          -  Complete PCL tear

          -  Complex menisci tears

          -  Contralateral knee ligament injury

          -  OA &gt; Grade II
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans Paessler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ATOS Clinic, Heidelberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Johan Bellemans, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven, Belgium</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Holger Schmitt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heidelberg University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gerhard Oberthaler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr. Pierer Sanatorium, Salzburg, Austria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Uwe Pietzner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dietrich-Bonhöffer-Klinik, Altentreptow, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Jagodzsinki, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hannover Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Pierer Sanatorium</name>
      <address>
        <city>Salzburg</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dietrich-Bonhöffer-Klinik</name>
      <address>
        <city>Altentreptow</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ATOS Clinic</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2008</study_first_submitted>
  <study_first_submitted_qc>October 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2008</study_first_posted>
  <last_update_submitted>August 7, 2011</last_update_submitted>
  <last_update_submitted_qc>August 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 9, 2011</last_update_posted>
  <responsible_party>
    <name_title>Rebecca L Horan, PhD</name_title>
    <organization>Serica Technologies, Inc.</organization>
  </responsible_party>
  <keyword>ACL</keyword>
  <keyword>Ligament</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

